NO20014077L - Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid - Google Patents

Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid

Info

Publication number: NO20014077L
Authority: NO; Norway
Prior art keywords: trifluoromethylphenyl; isoxazole; crystallizing; carboxamide; methyl
Prior art date: 1999-02-26

Application number

NO20014077A

Other languages

English (en)

Other versions

NO20014077D0 (no

NO319830B1 (no

Inventor

Hans-Hermann Lau

Udo Hedtmann

Holger Faasch

Andreas Gappisch

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-26

Filing date

2001-08-22

Publication date

2001-10-24

2001-08-22 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2001-08-22 Publication of NO20014077D0 publication Critical patent/NO20014077D0/no

2001-10-24 Publication of NO20014077L publication Critical patent/NO20014077L/no

2005-09-19 Publication of NO319830B1 publication Critical patent/NO319830B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20014077A 1999-02-26 2001-08-22 Fremgangsmate for krystallisering av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid NO319830B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19908527A DE19908527C2 (de)	1999-02-26	1999-02-26	Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
PCT/EP2000/001151 WO2000050411A1 (de)	1999-02-26	2000-02-12	Verfahren zur kristallisation von n- (4-trifluormethylphenyl) -5-methyl- isoxazol- 4-carboxamid

Publications (3)

Publication Number	Publication Date
NO20014077D0 NO20014077D0 (no)	2001-08-22
NO20014077L true NO20014077L (no)	2001-10-24
NO319830B1 NO319830B1 (no)	2005-09-19

Family

ID=7899073

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014077A NO319830B1 (no)	1999-02-26	2001-08-22	Fremgangsmate for krystallisering av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid

Country Status (22)

Country	Link
US (1)	US6303792B1 (no)
EP (1)	EP1155004B1 (no)
JP (1)	JP4625187B2 (no)
KR (1)	KR100626110B1 (no)
CN (1)	CN1127491C (no)
AR (1)	AR022737A1 (no)
AT (1)	ATE257828T1 (no)
AU (1)	AU762394B2 (no)
BR (1)	BR0008566B1 (no)
CA (1)	CA2363875C (no)
DE (2)	DE19908527C2 (no)
DK (1)	DK1155004T3 (no)
ES (1)	ES2214259T3 (no)
HK (1)	HK1043787B (no)
HU (1)	HU228918B1 (no)
IL (2)	IL144867A0 (no)
NO (1)	NO319830B1 (no)
NZ (1)	NZ513777A (no)
PL (1)	PL199365B1 (no)
PT (1)	PT1155004E (no)
WO (1)	WO2000050411A1 (no)
ZA (1)	ZA200106973B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19610955A1 (de) *	1996-03-20	1997-09-25	Hoechst Ag	Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
PT903345E (pt) *	1997-08-08	2001-01-31	Aventis Pharma Gmbh	Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida
CN1411373A (zh) *	1999-12-16	2003-04-16	特瓦制药工业有限公司	制备来氟米特的新方法和新晶形的来氟米特
US6723855B2 (en) *	2000-02-15	2004-04-20	Teva Pharmaceutical Industries Ltd.	Method for synthesizing leflunomide
CN107311954B (zh) *	2017-05-17	2020-04-07	力赛生物医药科技（厦门）有限公司	来氟米特晶型化合物、制备方法及其应用
CN114436894A (zh) *	2020-11-04	2022-05-06	欣凯医药化工中间体（上海）有限公司	泰瑞米特钠晶型及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2854439A1 (de)	1978-12-16	1980-07-03	Hoechst Ag	Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) *	1985-09-27	1987-04-02	Hoechst Ag	Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
HU222234B1 (hu) *	1990-05-18	2003-05-28	Aventis Pharma Deutschland Gmbh.	Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására
DE4127737A1 (de) *	1991-08-22	1993-02-25	Hoechst Ag	Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US5519042A (en) *	1994-01-13	1996-05-21	Hoechst Aktiengesellschaft	Method of treating hyperproliferative vascular disease
DE19734438A1 (de) *	1997-08-08	1999-02-11	Hoechst Marion Roussel De Gmbh	Kristallform von N-(4-Trifluormethylphenyl)-5-methyl-isoxazole-4-carboxamid
PT903345E (pt)	1997-08-08	2001-01-31	Aventis Pharma Gmbh	Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida

1999
- 1999-02-26 DE DE19908527A patent/DE19908527C2/de not_active Expired - Lifetime
2000
- 2000-02-12 PT PT00916829T patent/PT1155004E/pt unknown
- 2000-02-12 KR KR1020017010843A patent/KR100626110B1/ko not_active Expired - Lifetime
- 2000-02-12 DK DK00916829T patent/DK1155004T3/da active
- 2000-02-12 AU AU38038/00A patent/AU762394B2/en not_active Expired
- 2000-02-12 NZ NZ513777A patent/NZ513777A/xx not_active IP Right Cessation
- 2000-02-12 IL IL14486700A patent/IL144867A0/xx active IP Right Grant
- 2000-02-12 WO PCT/EP2000/001151 patent/WO2000050411A1/de not_active Ceased
- 2000-02-12 DE DE50005025T patent/DE50005025D1/de not_active Expired - Lifetime
- 2000-02-12 HK HK02104056.1A patent/HK1043787B/zh not_active IP Right Cessation
- 2000-02-12 EP EP00916829A patent/EP1155004B1/de not_active Expired - Lifetime
- 2000-02-12 AT AT00916829T patent/ATE257828T1/de active
- 2000-02-12 PL PL350422A patent/PL199365B1/pl unknown
- 2000-02-12 ES ES00916829T patent/ES2214259T3/es not_active Expired - Lifetime
- 2000-02-12 JP JP2000600994A patent/JP4625187B2/ja not_active Expired - Lifetime
- 2000-02-12 CA CA002363875A patent/CA2363875C/en not_active Expired - Fee Related
- 2000-02-12 HU HU0200058A patent/HU228918B1/hu unknown
- 2000-02-12 CN CN00804234A patent/CN1127491C/zh not_active Expired - Lifetime
- 2000-02-12 BR BRPI0008566-9A patent/BR0008566B1/pt not_active IP Right Cessation
- 2000-02-22 US US09/510,157 patent/US6303792B1/en not_active Expired - Lifetime
- 2000-02-24 AR ARP000100788A patent/AR022737A1/es active IP Right Grant
2001
- 2001-08-13 IL IL144867A patent/IL144867A/en not_active IP Right Cessation
- 2001-08-22 NO NO20014077A patent/NO319830B1/no not_active IP Right Cessation
- 2001-08-23 ZA ZA200106973A patent/ZA200106973B/en unknown

Also Published As

Publication number	Publication date
IL144867A0 (en)	2002-06-30
PT1155004E (pt)	2004-05-31
CA2363875C (en)	2008-04-29
JP4625187B2 (ja)	2011-02-02
AU762394B2 (en)	2003-06-26
KR100626110B1 (ko)	2006-09-20
EP1155004B1 (de)	2004-01-14
NO20014077D0 (no)	2001-08-22
CN1127491C (zh)	2003-11-12
NZ513777A (en)	2004-01-30
HK1043787B (zh)	2004-03-05
AU3803800A (en)	2000-09-14
WO2000050411A1 (de)	2000-08-31
DK1155004T3 (da)	2004-04-13
CN1341106A (zh)	2002-03-20
BR0008566B1 (pt)	2011-03-22
IL144867A (en)	2006-12-31
DE19908527A1 (de)	2000-08-31
HUP0200058A3 (en)	2004-07-28
PL199365B1 (pl)	2008-09-30
ES2214259T3 (es)	2004-09-16
PL350422A1 (en)	2002-12-16
AR022737A1 (es)	2002-09-04
KR20010103774A (ko)	2001-11-23
HUP0200058A2 (hu)	2002-05-29
JP2002537388A (ja)	2002-11-05
DE19908527C2 (de)	2001-08-30
ATE257828T1 (de)	2004-01-15
EP1155004A1 (de)	2001-11-21
CA2363875A1 (en)	2000-08-31
DE50005025D1 (de)	2004-02-19
US6303792B1 (en)	2001-10-16
HU228918B1 (en)	2013-06-28
ZA200106973B (en)	2002-08-22
HK1043787A1 (en)	2002-09-27
BR0008566A (pt)	2002-01-22
NO319830B1 (no)	2005-09-19

Publication	Publication Date	Title
NO20015156D0 (no)	2001-10-22	5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20014957D0 (no)	2001-10-12	Fremgangsmåte for fremstilling av aminplatinakomplekser
IS2223B (is)	2007-03-15	Aðferð til framleiðslu á 5-sýanóþalíði
NO20013569L (no)	2001-07-19	Fremgangsmate ved fremstilling av L-fenylephrine-hydroklorid
NO20040278L (no)	2004-01-21	Fremgangsmate for fremstilling av perindopril
NO20041850L (no)	2004-05-05	Fremgangsmate for dannelse av profenkrystaller
NO20030515D0 (no)	2003-02-03	Fremgangsmåte for fremstilling av dinapsolin
NO20014077L (no)	2001-10-24	Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid
NO20035586D0 (no)	2003-12-15	Fremgangsmåte for fremstilling av cykloheksanol-derivater
NO20001134D0 (no)	2000-03-06	FremgangsmÕte for fremstilling av VCM
NO20022956D0 (no)	2002-06-19	Fremgangsmåte for fremstilling av nitroguanidin
NO20013892L (no)	2001-08-09	Fremgangsmate for fremstilling av folieformede administreringsformer
NO20000805L (no)	2000-08-21	FremgangsmÕte for fremstilling av organiske azider
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20023702D0 (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20012811D0 (no)	2001-06-07	Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20020327D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20013044L (no)	2001-08-20	Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20020560L (no)	2002-02-05	Fremgangsmåte for fremstilling av cykloheksankarboksylsyrer
IT1312551B1 (it)	2002-04-22	Processo per la sintesi di 5-alchilbenzodiossoli
NO20006686D0 (no)	2000-12-28	Fremgangsmåte for fremstilling av ammoniakk
NO20002558D0 (no)	2000-05-18	FremgangsmÕte for fremstilling av findisperse eksplosivstoffer
EE200200053A (et)	2003-04-15	Isoretinoiini valmistamise protsess
SE9901814D0 (sv)	1999-05-16	Förfarande avseende framställning av granuler

Legal Events

Date	Code	Title	Description
2020-03-09	MK1K	Patent expired